Harrow Health, Inc. ( HROW) - Key Metrics
HROW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $2.42 | $0.18 | $0.23 | $0.22 |
| 2025Q3 | $1.93 | $0.03 | $0.45 | $0.44 |
| 2025Q2 | $1.73 | $0.14 | -$0.02 | -$0.03 |
| 2025Q1 | $1.34 | -$0.50 | $0.55 | $0.54 |
HROW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 67.96 |
| 2025Q3 | ? | 438.64 |
| 2025Q2 | ? | 56.24 |
| 2025Q1 | ? | -13.40 |
HROW Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -0.70% | ? |
| 2025Q4 | 0.45% | ? |
| 2025Q3 | 0.92% | ? |
| 2025Q2 | -0.09% | ? |
| 2025Q1 | 2.04% | ? |
HROW
Price: $34
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.38 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 114053
Market Capitalization: 1.2 billion